Quantification of the magnitude of thrombotic risk associated with malignancy and with anti-cancer therapy is indispensable to use anticoagulant drugs which selectively interfere with haemostatic mechanisms protecting patients from venous thromboembolism (VTE) and probably from tumor progression. However, none of activation coagulation markers has any predictive value for the occurrence of the thrombotic events in one individual patient. Current clotting methods can't reveal the overall dynamic clot formation; in contrast thromboelastographic methods specifically assess overall coagulation kinetics and its strength in whole blood.
Papa, M.L., Capasso, F., Pudore, L., Torre, S., Mango, S., Russo, V., et al. (2007). Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer. EXPERIMENTAL ONCOLOGY, 29(2), 111-5.
Thromboelastographic profiles as a tool for thrombotic risk in digestive tract cancer
Napolitano, M;
2007-01-01
Abstract
Quantification of the magnitude of thrombotic risk associated with malignancy and with anti-cancer therapy is indispensable to use anticoagulant drugs which selectively interfere with haemostatic mechanisms protecting patients from venous thromboembolism (VTE) and probably from tumor progression. However, none of activation coagulation markers has any predictive value for the occurrence of the thrombotic events in one individual patient. Current clotting methods can't reveal the overall dynamic clot formation; in contrast thromboelastographic methods specifically assess overall coagulation kinetics and its strength in whole blood.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Thromboelastographic profile.pdf
Solo gestori archvio
Dimensione
355.31 kB
Formato
Adobe PDF
|
355.31 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
